Australia's largest stock trading and investment forum Australia's #1 stock forum

WFL

Click for more information

0.00%

0.3¢ wellfully limited

Takeover, page-62

First 62 Last

Share
Profile

Follow
neutralopinions

2,369 Posts.

67

16/07/14

08:09

Post #: 13665160
Share

Originally posted by abdm ↑

Hi EO,

OBJ and NEU were two of three picks for the Biotech Tipping Comp. That is in no way or form attempting to compare the two company's at all, and I totally disagree with your, 'NEU at its worst and OBJ at its best' hypothesis. In fact I think you will be proven wrong on both counts... With a MktCap of $137m the market have yet to fully absorb the materially adverse impact the loss of an irreplaceable Dr Congreve will have on Neuren. He was Neuren, and whilst the company were very smart in securing a local favorite to try and fill those big shoes, only time will tell the real tale. Of course the science looks promising but it's still going to be a very tough gig moving forward. I would submit that in 5 years time Neuren can only dream of being where OBJ is right now. And, sure our market disagrees with this assessment today, as reflected in a lower market value for OBJ, but give it time - the market inevitably requires a lot of this in order to play catch-up.

In your defense I have to admit that you don't really fit the typical stereotype of a down ramping day trader, so in this regards some of the respondents which you have perceived to be making 'personal attacks' on you in reply to some provocative and at times somewhat lengthy posts (for a naysayer) may have been a little too quick to judge, however you do present unique characteristics in what often appears to be an unrelenting pursuit to plant a few negative seeds here on the OBJ forum.

Speaking from personal experience I also understand the hostility directed towards you on this forum because I have been on the receiving end on a countless times after choosing to share my own 'negative' sentiment/views on other stock forums - here's a couple of examples for your own reading pleasure:

GCN
ESI
IMU
MSB
MMZ
MOT
ANP
ISN
ALT

Whenever sharing a 'negative' view on a stock forum, regardless of whether you are posting facts or fiction, it's always important to remember that you are addressing people which are largely made up of the owners of that particular company, so one can never expect a warm reception with tea or coffee on arrival. I'm sure that you can already appreciate this, however from the perspective of those who get labelled as 'naysayers' it's easy to get caught up in the emotional game and in response to perceived personal attacks become even more determined to throw mud at the company.

Following a little dig at AS in one of my original replies to you a while back I've noticed that you've prompted me with similar comments to this one above on more than one occasion, so consider today your lucky day, albeit you may not necessarily be happy with what you read...

Are you aware that Alan's remuneration package in 2012 (including unrealized stock awards) came to a total figure that would be equivalent to the total combined salary and fees package paid to all OBJ directors in 2012 over the next 18.5 consecutive years?

Are you aware that Alan's remuneration package in 2012 (including unrealized stock awards) after the company reported a net loss of over $52m came to a total that was larger than the total revenue reported by UNS during that year?

Are you aware that Alan's remuneration package in 2012 would indicate to the majority of the world's working population, that he may never need to sell a single share in his lifetime?

Are you aware that previous allegations allude to the possibility that Alan may have also traded in company shares under the alias of... Come in Roger, where are you?

Are you aware that even though UNS has yet to make any public announcement to the ASX, on 08/01/2014, Unilife were served with a derivative complaint filed in the Delaware Chancery Court by Cambridge Retirement System, against the Board of Directors to recover allegedly “excessive and wasteful” compensation paid to the directors since 2010?

Unlike some of the lawsuits listed among the additional light reading material below it has also been alleged that this litigation filed by Cambridge Retirement System is likely a substantial lawsuit.

A little needle for the float boom

Shooting up on hype

Ex-lover sues for Unilife shares

Judge Orders Unilife Boss To Pay Back Loan, Plus A Margin

WHITE v SHORTALL SUPREME COURT OF NEW SOUTH WALES

That's Quite A Shot In The Arm

Seperation Agreement and General Release

VARRATO v UNILIFE, et al - Civil Action No. 1:11-CV-398

How is a $329m Syringe Company Still Unprofitable After 11 Years?

Former VP Claims Unilife Retaliated Against Him for SEC Whistleblowing

Former Executive's New Lawsuit Alleges Investor Fraud, SEC Violations

Would It Be Foolish to Trust Unilife?

Pomerantz Law Firm Files Class Action Against Unilife

Ryan & Maniskas Announces Class Action Lawsuit Against Unilife

Rigrodsky & Long Files Class Action Lawsuit Against Unilife

Robbins Arroyo files federal securities fraud class action against Unilife

BYRON BRANDT et al v. UNILIFE CORPORATION et al

Why this hypodermic needle company keeps jabbing investors

Quarterly Results Reveal Mounting Operating Losses, Continued Dilution, And Ambiguous Growth Plan

Expand

Would you also be kind enough to explain what happened in 2002/2003 when the company was suspended from ASX and placed in voluntary administration ?

That a company's focus shifted massively from selling Telephones to Biotech ?

OBJ Price at posting: 8.3¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 18 more messages in this thread...

First 62 Last

Add WFL (ASX) to my watchlist